Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.57), $0.11 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $28.06 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.